Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price traded down 1.2% on Thursday . The stock traded as low as $5.55 and last traded at $5.55. 12,849 shares were traded during trading, a decline of 29% from the average session volume of 18,080 shares. The stock had previously closed at $5.62.
Ono Pharmaceutical Price Performance
The firm’s fifty day simple moving average is $4.97 and its 200-day simple moving average is $4.36.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Read More
- Five stocks we like better than Ono Pharmaceutical
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Unlocked: Elon Musk’s Next Big IPO
- Buy this stock tomorrow?
- This makes me furious
- The free stock picks nobody’s talking about
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
